Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5626_Библиотеки_им_академика_М_И_Перельмана.pdf
16.3 Pharmacological Mechanism and Toxicity Profile of Some Common Natural Pesticides and Anti-allergens 321
Eurotium, exposures are believed to play a protective role
against allergies [62]. Bacterial lysates contain fragments of
bacteria which, when introduced to the body, can activate
the immune system in a non-pathogenic way. Examples of
bacteria used for lysate production include Haemophilus
influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. These lysates can modulate the immune system, pote-
ntially reducing allergic sensitization and symptoms [63].
16.3 Pharmacological Mechanism and Toxicity Profile of Some Common Natural Pesticides and Anti-allergens
16.3.1 Natural Pesticides or Biopesticides
16.3.1.1 Azadirachtin
Azadirachtin is a predominant biopesticide obtained from
Neem fruit preparations i.e. Azadirachta indica A. Juss. It
hinders insect development, acts as an antifeedant, and is
detrimental to them [64]. The existence of the multifaceted limonoid (tetranortriterpenoid) as a main phytometabolite is what induces this action. These preparations
contain other limonoids such as nimbolide, salannin, and
nimbin. The Pesticide Standard states that preparations
containing azadirachtin (25%) and additional limonoids
(30–50% w/w) as effective chemicals are used to synthesize neem emulsion. In the view of Mordue and Blackwell,
the pharmacological impact of azadirachtin pesticidal
activity is a result of (i) significant actions on the majority
of insect organs; (ii) juvenile and ecdysteroid hormone
impacts; and (iii) azidirachtin action on chemoreceptors
promotes antifeedancy [65]. Female and male rats were
used in subchronic investigation (90 days) of azadirachtin
at 500, 1 000, and 1 500 mg kg
and male rats treated with azadirachtin did not exhibit any
toxicological signs in kidney, liver, organ weight, and mortality at any of the examined dosages [66].
16.3.1.2 Abamectin
A biopesticide with gastrointestinal action is called
abamectin. Streptomyces avermitilis was used in the fermentation process to develop abamectin. Abamectin is a
neurotoxicant exhibiting a distinctive mode of action. It
works by inhibiting the ionotropic γ-amino butyric acid
(GABA) in the neurological system [67]. The reported oral
for abamectin in rats is 221 mg kg−1 in water and
LD
50
10 mg kg−1 in sesame oil for rats. Female and male rats
were given abamectin orally for 28 days at a dosage of
2.13 mg/animal/day, resulting in liver injury. Following the
treatment time, the rat was maintained for a withdrawal
−1
per day dosages. Female
interval of 14 days without any therapy. In both female and
male rats, abamectin markedly upregulated the level of
liver function enzyme γ-glutamyl transpeptidase (GTP),
aspartate aminotransferase (AST), and alanine transaminase (ALT) [68].
16.3.1.3 Nicotine
Nicotine is a dinitrogen toxic alkaloid that is extracted
from the leaves of Nicotiana tabacum and possesses a significant tradition of use as a pesticide. Concentrated nicotine is highly poisonous to animals (LD
= 50 mg kg−1 for
50
rats) and promptly absorbed through the skin in humans,
therefore its use has diminished. Nowadays, it is mostly
used as a fumigant in greenhouses to control insects.
Nicotine is a very effective neurotoxicant affecting both
animals and insects. It binds to nicotinic cholinergic
receptors at neuron junctions and induces unregulated
neuronal bursting, competing with acetylcholine, the primary neurotransmitter [69].
16.3.1.4 Bacillus thuringiensis (Bt)
A distinctive type of gram-positive bacteria called Bt is
capable of synthesizing a range of pharmacological molecules that are employed as pesticides in the commercial,
farming, and public healthcare domains [70]. Bt is a natural pesticide that is utilized extensively because of its effectiveness for humans and ecosystem friendliness. Delta
endotoxin is released by Bt during the germination cycle.
It appears to be a crystalline protein that possesses pesticidal characteristics. Following Bt treatment and insect
intake, delta endotoxin crystals become dissociated and
induce the destruction of the stomach epithelial cells. As
an outcome, insects discontinue ingesting and eventually
die from starvation [71]. According to Lemos et al. pregnant rats given a dosage of 370 mg/100 g of Bttoxin
(XenTari®), which is equivalent to 20 mg/100 g of the protoxin, develop progressive glomerulonephritis, necrosis,
and tubular atrophy in their kidneys. The researchers predicted that the change in the kidney following treatment
to Bt toxins is caused by toxins’ impact on the immunological mechanism through mesangial cell growth and
their invasion in the renal tissue [72].
16.3.1.5 Ryania
Ryania is a biopesticide produced by a stem of Ryania speciosa belonging to the family Flacourtiaceae, a native tree
of Central America. Ryanodine (diterpenoid derivative) is
the primary alkaloid included in the stem preparation [73].
Ryania is a delayed-onset gastrointestinal toxin. Insects
cease eating shortly after consuming it, even though it fails
to immediately induce knockout immobility. Ryania is
322 16 Pesticides and Allergens
reportedly most efficient in hot temperatures and piperonyl butoxide works together well. The acute gastric LD
50
measurement of Ryania in rats is 1200 mg kg−1. Pancreatic
necrosis, weight loss, and a 100% mortality rate were
reported in rats following oral Ryania treatment at a dosage
−1
of 2700 mg kg
16.3.1.6 Spinosad
per day [73].
Spinosad is a biopesticide synthesized by the fermentation
of Saccharopolyspora spinosa (soil actinomycetes) [74].
Spinosad is classified as a specific pesticide as a result of its
minimal toxicity as well as its efficacy. Targeting the GABA
and nicotinic cholinergic receptors is the way a neurotoxin
called spinosad works. The LD
value of acute oral toxicity
50
in male rats is 3 783 mg kg−1 while female rats have an
of more than 5 000 mg kg−1. Santos et al. examined
LD
50
the spinosad-related impacts on reproduction in rats
throughout two successive cycles. Spinosad was given
orally to rats for two cycles at dosages of 3, 10, and
−1
100 mg kg
. Oral spinosad treatment at a dose of
100 mg kg−1 results in placental toxicity and negative
effects on the progeny. The researchers claimed that spinosad at reduced dosages had no negative effects [75].
16.3.1.7 Pyrethrins
A plant-based molecule called pyrethrins is isolated from
the flowers of Chrysanthemum cinerariifolium belonging to
the family Asteraceae [76]. Additionally, pyrethrins are
listed as pesticides, and there are over 2 000 marketed formulations available globally. Pyrethrins have an insecticidal
impact that is associated with a quick knocking effect, especially in flying insects, as well as excitability and tremors in
the majority of insects. The neurotoxicant activity of pyrethrins, which shuts off voltage-gated sodium channels in
neuronal axons, induces those complaints. It also has neuropharmacological impacts on cholinergic, noradrenergic,
GABA, and dopaminergic neural transmission [77]. The
reported oral LD
value for pyrethrins is based on the
50
Pesticide Guideline is 273–796 mg kg−1 for mice and 1 030
−1
and 2 370 mg kg
ment with pyrethrins at a dose of 1 000 mg kg
for female and male rats [78]. Oral treat-
−1
per day in
experimental rodents including rabbits, mice, and rats demonstrated liver impairment and hepatotoxicity. Pyrethrins
markedly upregulated the level of liver function enzymes
including alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), and total protein [79].
16.3.1.8 Rotenone
Rotenone is a broad-spectrum and selective biopesticide
that has been exploited for over 150 years, but its usage as a
fish toxin stretches back much longer. Rotenone is extracted
from the stems, rhizomes, seeds, leaves, and roots of the
subtropical region species, i.e. Tephrosia virginiana, Derris
elliptica, and Lonchocarpus utilis. Rotenone is a mitochondrial toxin that hinders energy development by obstructing
the electron transport chain (complex-I activity). Rotenone
predominantly targets the skeletal muscle and neural cells
of insects, where it has lethal actions that quickly stop eating. Mortality appears from a few hours to days following
ingestion. The reported oral LD
350 mg kg
−1
for mice and 132–1500 mg kg−1 for rats.
value for rotenone is
50
Fetotoxicity was observed in guinea pigs treated with rote-
−1
none at a dosage of 9 mg kg
per day [80].
16.3.2 Pharmacological Mechanism and Toxicity of Natural Anti-allergens
16.3.2.1 Tussilagone
The flower buds of Tussilago farfara L. are the origin of
tussilagone (a sesquiterpenoid derivative), a botanical
anti-allergen. A cytokine called interleukin-6 has significance for the onset and severity of allergic rhinitis (AR).
Intraperitoneal administration of tussilagone at a dosage
−1
of 25–50 mg kg
has demonstrated a downregulation in
IL-6 expression in ovalbumin-induced AR in guinea pigs.
A different investigation has demonstrated that suppressing the mitogen-activated protein kinase (MAPK)
and nuclear-factor kappa-B (NF-κB) cascades substantially reduced the level of IL-6 and IL-1β mRNA in
lipopolysaccharide-induced AR [81].
16.3.2.2 Mangiferin
Mangiferin (a glucosyl xanthone derivative) is a bioactive
phytometabolite obtained from Mangifera indica. In
comparison to the ovalbumin-treated group, extracted
mangiferin substantially reduced mast cells, goblet cells,
and eosinophil counts when administered at a dosage of
−1
5 and 20 mg kg
. The outcomes revealed a comparable
substantial change in the count of mast cells, goblet cells,
and eosinophils in the experimental animal given dexa-
−1
methasone at 2.5 mg kg
16.3.2.3 Shikonin
[82].
Shikonin (a 1,4-naphthoquinone derivative) has been
obtained from dried roots of Lithospermum erythrorhizon. In
a rat model of ovalbumin-mediated AR, shikonin was investigated for its potential to prevent IgE synthesis throughout
an allergic event. Intraperitoneal shikonin administration at
−1
a dose of 200, 400, and 600 μg kg
results in downregulation
of serum IL-4 concentration and ovalbumin-specific IgE and
upregulation of serum IFN-γ concentration as compared to
the disease control group. Moreover, the nasal mucosal
membrane of the shikonin-treated groups expressed higher
T-bet protein and reduced GATA-3 protein. In contrast to the
negative control group, the results showed an upregulation
16.4 Global Market Surveillance of Biopesticides and Anti-allergens 323
in the serum level of glutathione peroxidase (GPx) and
superoxide dismutase (SOD) and a downregulation of
malondialdehyde (MDA) level [83].
16.3.2.4 Okicamelliaside
Okicamelliaside (a glucoside of ellagic acid derivative) is a
bioactive molecule obtained from leaves of Camellia japon-
ica. Okicamelliaside is an effective degranulation inhibitor
and may be able to inhibit an allergic response in vivo. Male
BALB/c albino mice were activated with Japanese cypress
pollen grains and exposed to nasal administration of the
antigen in an in-vivo investigation to test the efficacy of the
molecule in suppressing AR. Intraperitoneal treatment of
okicamelliaside at a dosage of 0.2 mg kg
depicted a reduction in the number of sneezing times in
mice within 10 minutes following the exposure. In contrast
to ketotifen fumarate, an anti-allergic therapeutic used as a
standard, okicamelliaside inhibited sneezing 12 000 times
more effectively [81].
−1
for 24 days,
16.4 Global Market Surveillance of Biopesticides and Anti-allergens
The global marketplace for biopesticides is expanding and
changing significantly on a worldwide scale. Traditional
chemical pesticides are being replaced with biopesticides,
which are made from natural resources including plants,
microorganisms, animals, and mineral resources. In the
present situation of the biopesticides market, numerous
studies were conducted, looking at its growth trajectory,
geographical distribution, types of biopesticides in use, and
expectations for the future [84]. In many regions of the
world, the conversion from synthetic pesticides to biopesticides is growing more and more prominent. Despite certain difficulties and uncertainties, it is projected that the
growing trend of using biopesticides will have a significant
impact on environmentally friendly farming and environmental preservation [85].
The US$ 56 billion global pesticide industry is now dominated by biopesticides, presently accounting for between
US$ 3 and 4 billion. The use of biopesticides may ultimately
overtake the consumption of conventional pesticides given
the sector’s 14.1% CAGR each year [86]. By geographic
location, North America uses over 40% of the world’s
biopesticide generation, and by the completion of the decade, the US market is expected to reach up to US$ 300 million. In 2010, the market in Europe was worth around US$
270 million. South and Latin American markets are likewise slowly growing [87]. Five microbiological items were
reportedly marketed in the United Kingdom, compared to
10 in Germany and 15 in the entire Netherlands and France
[88]. As they enhance their use of biopesticides, Asian
nations notably China and India offer tremendous development prospects. Currently, 2.89% of all pesticides marketed globally are biopesticides, which is a modest portion.
Bt-based products, Bacillus subtilis, and Bacillus fluorescens
are the most often utilized biopesticides when analyzing
the many types of biopesticides. Additionally, the use of
fungi and nematodes as biopesticides is developing. Even
though the usage of biopesticides is expanding internationally, the sector should grow much more in the next years to
displace chemical pesticides. It is recommended that this
emphasizes industry and research institution cooperation
as well as the more practical use of research discoveries
[87]. However, registering biopesticides in diverse areas is
not without its difficulties. The registration process in the
European Union is referred to as “extremely drawn-out
and challenging,” which leads to a decrease in the quantity
of biopesticides approved. Similar concerns are expressed
in Nigeria, where governmental restrictions and inadequate infrastructure hinder the use of biopesticides [87].
Biopesticides come in a variety of forms, such as nematodes, fungi, viruses, and microbial substances like Bt.
Products based on Bt are particularly prevalent, accounting
for more than 53% of the total market for biopesticides
internationally [89].
Biopesticides are expected to represent over 7% (US$ 4.5
billion) of the global agricultural protection market by
2023, growing at an overall annualized rate of 8.64%. By
late 2040 or early 2050, it has been estimated that biopesticides would overtake synthetic pesticides in market share
[89]. India has gradually expanded its yearly application of
biopesticides over the years, with equivalent figures of
8847 and 8645 metric tonnes in 2019–2020 and 2020–2021,
respectively [90]. Even if the use of biopesticides is expanding, their introduction in places like Southeast Asia and
Africa remains unclear. To completely substitute chemical
pesticides, this company has to expand. It is crucial to
stress the value of research and partnerships between companies and academic institutions to promote extensive
industrial growth. Overall, it offers a thorough analysis of
the biopesticide economy, including information on its
development prospects, geographical variances, difficulties, and the function that various types of biopesticides
perform in the industry. It represents a trend away from
chemical pesticides in the direction of biopesticides as a
result of increasing concerns about the environment and
regulatory constraints [91]. Anti-allergens are crucial
weapons in the fight against allergies. By minimizing the
effects of allergens and minimizing the intensity of allergic
responses, they help people live healthier, better pleasant
lives. A tailored strategy for controlling allergies is implemented since the anti-allergen chosen relies on the distinctive allergy triggers and manifestations confronted by each
individual [92].
324 16 Pesticides and Allergens
Global Market representation of Biopesticides &
30
25
20
15
10
5
Global Market (USD Billion)
0
Figure 16.1 Global representation of the market value of both biopesticides and anti-allergens.
14.7
1.3
2011 2017 2023 2028
Biopesticides
The global anti-allergy medicine market is expected to
grow at a CAGR of 6.8% from 2020 to 2027, with an initial
estimated value of US$ 24.8 billion in 2020 to US$ 39.3 billion by 2027, irrespective of the COVID-19 outbreak
[93, 94]. According to the report, one of its sectors, pharmacy, will surpass US$ 23.2 billion by the completion of the
analysis period and increase at a 7.6% CAGR. Following an
initial analysis of the pandemic’s effects on business and the
resulting financial instability, the Hospital segment’s development plan has been adjusted to target a 6.1% CAGR [93].
It is projected that the US market for anti-allergy drugs
would grow to US$ 6.7 billion by 2020. China’s economy,
which is now the second biggest in the world, is projected to
expand at a compound annual growth rate (CAGR) of 10.5%
between 2020 and 2027, reaching an estimated market
value of US$ 8.7 billion. Japan and Canada are two more
noteworthy regional markets that are expected to increase
at respective rates of 3.6 and 6.1% between 2020 and 2027.
Germany is expected to expand within Europe at a rate of
about 4.3% CAGR [93] (Figure 16.1).
3.2
Anti-allergens
28.74
19.69
Year
Anti-allergens
19.47
11.75
4.5
manufactured chemicals (Table 16.3). The increased
understanding of the negative effects of conventional pesticides and allergenic chemicals on the environment and
human health has caused this transition [28].
The commercial manufacture and formulation of natural pesticides and anti-allergens in an industry that is
quickly expanding due to (a) increasing public awareness
of the potential health and environmental risks linked with
synthetic chemicals; (b) growing demand for sustainable
and eco-friendly products; and (c) rising prevalence of
allergies and other chronic health conditions [95].
Natural pesticides and anti-allergens can be derived from
a wide range of plant and animal sources, including plants
(neem oil, pyrethrum, rotenone, garlic, chili peppers, and
essential oils), animals (diatomaceous earth, chitosan, and
propolis), insects and marine organisms (Neopestalotiopsis
spp., Xenorhabdus, Photorhabdus, bromotyrosine derivatives, halogenated compounds from algae, chitosan from
shrimp and crab shells and marine microbial enzymes).
The specific extraction and formulation methods used will
vary depending on the active ingredient’s nature and the
product’s intended use.
16.5 Commercial Production and Formulations of Natural Pesticides and Anti-allergens
16.5.1 Commercial Production of Natural Pesticides
Natural anti-allergens and pesticides are essential to contemporary healthcare and agriculture respectively. In
recent years, there has been a substantial trend toward
environmentally friendly and sustainable methods, encouraging the application of natural substitutes rather than
The commercial production of natural pesticides can be
divided into two main steps:
• Step I: Extraction of the active ingredient: This can be
done using various methods, such as solvent extraction, supercritical fluid extraction, and distillation.
16.5 Commercial Production and Formulations of Natural Pesticides and Anti-allergens 325
Table 16.3 Commercial production and formulations of natural pesticides and anti-allergens.
Aspect Natural pesticides Natural anti-allergens
Source Plants, bacteria, and minerals. Plants, insects, and microorganisms
Types Botanical, microbial, and biochemical. Botanical and microbial.
Production Stages Source material selection, extraction, formulation,
Formulations Emulsifiable concentrates, powders, granules, and
Efficacy Varies based on source and formulation. Targeted toward specific allergic reactions and
Stability and Shelf
Life
Challenges Consistency, standardization, regulatory compliance,
Opportunities Eco-friendly, health-conscious market, and
and quality control.
oils, etc.
Generally shorter compared to synthetic pesticides. Varies based on formulation and storage
efficacy.
technological advancements.
Research, formulation, clinical trials, regulatory
approval, and manufacturing.
Tablets, nasal sprays, injections, sublingual drops/
tablets, patches, and immunotherapy extracts.
symptoms.
conditions.
Efficacy, standardization, cost-effectiveness, and
regulatory compliance.
Growing health concerns, increased R and D, and
consumer preference for natural alternatives.
• Step II: Formulating the pesticide: To make a simple
and effective product, the active component must be
combined with additional substances. This might
include adding emulsifiers, surfactants, solvents, and
other chemicals [96].
16.5.2 Commercial Production of Natural
Anti-allergens and Formulations of Natural
Pesticides and Anti-allergens
Several significant distinctions exist between the commercial production of natural anti-allergens and natural insecticides. For instance, anti-allergens are often prepared as
capsules, pills, or powders used orally and generally produced from plant sources. Another significant distinction
is that anti-allergens are often not created to destroy or
repel allergens. They function instead by controlling the
immune system and lowering the body’s susceptibility to
allergens. Both natural insecticides and anti-allergens
come in a range of formulations. Following are some of the
most typical formulations [81]:
• Sprays: Sprays are the most common formulation for
natural pesticides. They are easy to apply and can
cover large areas quickly. However, sprays can be less
effective than other formulations in certain situations,
such as when applied in windy conditions [97].
• Granules: Granules are an excellent choice for pesti-
cides that must be applied to the soil. They are slowrelease and can provide long-term protection against
pests. However, if not applied evenly, granules can be
less effective than other formulations [98].
• Baits: Baits are used to attract and kill target pests. They
can be effective against various pests, including insects,
rodents, and snails. However, baits can be hazardous to
non-target animals, such as pets and wildlife [99].
• Capsules and tablets: Capsules and tablets are the
most common formulations for natural anti-allergens.
They are easy to take and can be carried with you.
However, capsules and tablets can be less effective than
other formulations if they are not taken regularly [99].
• Powders: Teas, smoothies, and other culinary items
may be made using powders. They may also be put on
the skin or hair straight. However, applying powders
may be messy and challenging to combine [98].
16.5.3 Challenges and Opportunities in the
Commercial Production and Formulations of
Natural Pesticides and Anti-allergens
A rapidly expanding business, commercial manufacturing
and formulation of natural pesticides and anti-allergens
also confront several difficulties. The absence of standards
in manufacturing and formulating natural goods is one of
the main problems. Consumers may find it challenging to
compare items and evaluate their quality and safety as a
result [100]. The lack of information on the effectiveness
and safety of natural pesticides and allergies is another
problem. This is because less research has been done on
these items than on manufactured chemicals. Nevertheless,
the body of knowledge about natural pesticides and allergies is expanding quickly and more and more information
is becoming accessible. Despite these challenges, the commercial production and formulation of natural pesticides
and anti-allergens present several opportunities. The
global market for natural pesticides is expected to reach
$12.8 billion by 2028, and the global market for natural
326 16 Pesticides and Allergens
anti-allergens is expected to reach $11.5 billion by 2028.
The main drivers of this expansion are growing public
awareness of the possible health and environmental concerns connected with synthetic chemicals and an increase
in consumer demand for environmentally friendly and
sustainable goods [101]. Natural anti-allergens and pesticides promise to advance sustainable agriculture and
enhance public health. Their commercial manufacturing
demands a thorough and organized procedure, from locating natural resources to creating efficient goods.
Addressing issues like effectiveness and stability is crucial
to fully reap the benefits of these natural alternatives.
Natural pesticides and anti-allergens are set to play a significant part in defining a healthier and more ecologically
aware future as research and technology improve [102].
16.6 Regulatory Aspects for Quality Control of Pesticides and Anti-allergens
16.6.1 Regulatory Standard for Pesticides
Pesticides are governed by international law in several
areas, particularly commerce, border control, agriculture,
human health, and the environment. The Food and
Agriculture Organization of the United Nations published
the International Code of Conduct on Pesticides in 1985,
which establishes unified criteria for governments and the
pesticide industry in general [90]. Numerous more international treaties have been adopted since then, including the
Stockholm Convention and the Rotterdam Convention.
Moreover, safety is the goal of internationally coordinated
chemical categorization and labeling systems [103]. To
ensure efficient and persistent pesticide management,
measures including IPM, product incentives for safer alternatives, training, education, and research should be implemented in addition to the regulations. Legislation serves as
a foundation for these initiatives [89].
Governmental organizations around the world possess a
significant responsibility in regulating the use of pesticides
since neither manufacturers nor consumers are likely to
limit their sales or usage of pesticides. Through a rigorous
registration procedure that requires testing under four different climatic conditions and the submission of toxicological information relevant to Indian settings, the quality of
pesticides is maintained. In India, a comprehensive legislative framework, “The Insecticides Act, 1968,” and its related
rules oversee the importation, manufacturing, sale, transportation, and use of pesticides. The Central Insecticides
Board requires registration for every pesticide product
intended for production, importation, or usage in India.
Furthermore, a license is required for any organization
involved in the marketing, storing, or distribution of pesticide goods. The Board is given the authority by the law to
prohibit or restrict the use of certain pesticide products. As a
consequence, the Indian government has banned over 30
pesticides, placed limitations on 7 pesticides, including DDT,
and refused to grant registration to 18 chemicals [104].
Additionally, India has created a Bureau of Indian Standards
that regulates the pesticide spraying equipment utilized.
However, it is essential to strengthen the implementation of
laws and regulations at the local level to prevent the theft
and inappropriate use of pesticides using equipment that
does not meet the required levels of quality [97]. The
Insecticide Act requires that insecticides be registered. The
use of chemical pesticides is only permitted after careful
examination and approval by the Registration Committee,
which takes into account comprehensive data regarding
their effectiveness and safety for various aspects including
humans, wildlife, birds, domestic animals, beneficial parasites, and predators. The goal of the insecticide regulations is
to promote the use of pesticides safely. This includes rules on
suitable clothing, breathing equipment, antidotes, first aid
supplies, worker training, and the right disposal of empty
containers, extra ingredients, and pesticide residue. It also
includes restrictions on these topics and more. Regular evaluations of registered pesticides are conducted by the
Registration Committee, and the Ministry of Agriculture
considers its suggestions. As a matter of policy, the committee has decided not to register pesticides with WHO classes
IA and IB unless a compelling argument is made [104].
16.6.2 The Regulatory Standard for Anti-allergens
Current legislation and standards have given food allergen
immunotherapy (AIT) related allergy products. The existing and approved AIT medicines right now mostly treat
aeroallergens and allergies to insect venom. Compared to
information accessible for food AIT products, the guidance
offered for these goods is far more detailed. Examining a
standard manufacturing procedure for a food AIT product
makes this clear. When the meal is delivered via oral immunotherapy (OIT), the production procedure from the raw
components to the completed product may only need a few
key steps. As a result, the active ingredient becomes quite
close to the original chemical, if not precisely the same.
However, the manufacture of the active component must
follow pharmaceutical Good Manufacturing Practice
(GMP) procedures in compliance with current GMP principles. The crucial question is which precise process the
food source material must go through to be manufactured
and controlled by pharmaceutical GMP criteria [105]. The
16.7 Future Prospects and Opportunities 327
production of biological medical products must follow
pharmaceutical GMP and be validated by EU-GMP requirements. This includes several manufacturing processes,
such as particle size modification or pre-treatment (such as
milling). The strictness of GMP in the production of active
substances grows gradually from the first stages to the finishing touches, purification, and packaging [106].
Analytical characterization of food allergies becomes
more complicated. Aeroallergen-containing AIT products
frequently involve an extraction process that yields an
aqueous solution containing both protein and non-protein
constituents. Several studies may be conducted using these
aqueous solutions, including IgE ELISA inhibition assays
to determine the overall allergenic sensitivity. However,
manufacturing food allergy products might not be able to
use a similar extraction method. In OIT for food allergens,
these allergens are commonly administered as flour, which
is blended into a vehicle food for subsequent ingestion by
the patient [106]. Last but not least, allergen products
intended for therapeutic use are often distinguished by a
biological potency, which is subsequently translated into
the medical products advertised strength. Direct comparisons between goods from other manufacturers might be
difficult since this declared strength is often represented in
manufacturer-specific biological units. However, the
amount of protein in a specific dietary AIT product is frequently standardized and labelled. In such cases, it’s essential to establish a correlation between the biological
potency, primarily determined through a competitive IgEbinding test, and the protein content. This correlation
ensures that the labelled strength (in this case, the protein
content) remains indicative of the allergenic potency of the
product. It is crucial to guarantee that the patient receives
a product with regulated quality that is constant throughout. This applies to both the initial dose escalation and the
subsequent maintenance phase of OIT. It is essential to
ensure that an OIT product’s quantitative and qualitative
properties are well-controlled and fall within predetermined limits [107].
16.7 Future Prospects and Opportunities
Emphasizing non-chemical and cultural pest management
methods, such as removing exhausted plant parts, rotating
crops to potentially disturb pest life cycles, and using insect
predators for biological control. To lessen the prevalence
and availability of toxic pesticides, the UN Food and
Agriculture Organization and the Convention on Persistent
Organic Pollutants are working internationally. To foresee
the possible risks of pesticides and consequently minimize
the harmful effect on human health and the natural ecosystem, new procedures that are more reliable are required
[108]. Through technical assistance and training for manufacturers, raise the quality of products and sales. In the
early phases of its advancement, there is an urgent requirement for greater interaction between consumers, researchers, and companies to advance biopesticide research. The
government should keep enforcing stringent regulations
on synthetic pesticides. It will provide several opportunities for biopesticide promotion, bridging the gap and
improving the affordability of biopesticides [109]. Utilizing
our growing understanding of pest genomes and their
innate predators will lead to the most important advancements in biopesticides. Researchers are deciphering the
biological foundation for the pathogenicity of natural
microbial adversaries and reconstructing the emergence of
those adversaries using molecularly based technologies. It
is required to do ecological research on the dynamics of
illness in the pest population. To reap the most benefits
from using biopesticides, farmers need to receive proper
training. The main restrictions include educating farmers
on the management and use of biopesticides; farmers
should get sufficient instruction to effectively employ these
environmentally friendly pest control options in their agricultural areas [110]. In the disciplines of agriculture, medicine, pharmaceuticals, and pest control, nanoparticles
have a variety of uses. Despite their small size, stability,
improved solubility, mobility, and reduced toxicity, nanobiopesticides are a great alternative to traditional pesticides.
Pesticides that have nanoparticles in their composition are
used to address these problems. Nano biopesticides can be
evaluated towards a particular insect to see how well they
work on various crops. Nanobiopesticides have particular
actions against various pests, such as suicidal, larvicidal,
and anti-feeding actions. Regulatory practices will affect
the use of biopesticides in the future. The amalgamation of
microbiological and biochemical compounds in biopesticide instances via transgenic substrates is taking shape,
creating possibilities and influencing the problems and
advancement of biopesticides [111].
Anti-allergens, which are chemicals or therapies
intended to lessen or prevent allergic responses, have a
bright future ahead of them because of developments in
research and technology as well as the rising incidence of
allergies. There is an increasing possibility for individualized anti-allergen therapies as our knowledge of the
genetic and molecular causes of allergies advances.
Immunotherapy advancements like allergy injections and
sublingual immunotherapy may become more efficient
and tailored as a result of treating patients according to
their unique genetic makeup and allergies. Future developments in this field might lead to the creation of more
328 16 Pesticides and Allergens
patient-friendly and practical delivery systems, including
OIT pills or even at-home treatments. The treatment of
several medical disorders has been transformed by biological medications and monoclonal antibodies. Future
research might lead to the creation of monoclonal antibodies and biologics that are specially made to target and
neutralize allergens, offering a more specialized method
of treating allergies [111]. Improved allergen vaccinations
are being developed by researchers to lessen allergic
responses. These vaccinations might be created to provide
long-lasting relief from a wider spectrum of allergies.
Drug delivery techniques may undergo a revolution
thanks to nanotechnology. Nanoscale drug delivery
devices may be used in future anti-allergen therapies to
enhance the absorption and efficacy of allergy drugs
while reducing adverse effects. New environmental and
home technology may offer more effective solutions to
manage allergies in both indoor and outdoor settings.
This may involve enhanced air purifiers, construction
materials that are resistant to allergens, and improved
strategies for avoiding allergens [111]. Clustered regularly
interspaced short palindromic repeats (CRISPR) and
other gene-editing tools offer the ability to attack the
genetic foundation of allergies. Even while research in
this field is still in its infancy, it shows promise for maybe
avoiding or lessening allergies through genetic modifications. increasing financing for allergy research, which in
turn can spur advancements in anti-allergen therapies, is
anticipated to result from increasing knowledge of allergies and their effects on public health [111].
Acknowledgments
The author(s) express gratitude to the Bina Chowdhury
Central Library of Girijananda Chowdhury University,
Guwahati, India, for granting access to essential internet
services and enabling the successful completion of the literature survey. This included access to subscribed journals
and reference books, crucial for the research endeavor.
Conflict of Interest
All authors declare no conflict of interest.
Funding
None
References
1 Rani, L., Thapa, K., Kanojia N. et al. (2021). An
extensive review on the consequences of chemical
pesticides on human health and environment. Journal
of cleaner production 283: 124657.
2 Zou, M., Huang, M., Zhang, J. et al. (2022). Exploring
the effects and mechanisms of organophosphorus
pesticide exposure and hearing loss. Frontiers in Public
Health 10: 1001760.
3 Pattnaik, M., Pany, B., Dena, J. et al. (2020). Effect of
organochlorine pesticides on living organisms and
environment. Chemical Science Review and Letters 9:
682–86.
4 Mittal, C., Singh, S., Kumar-M. P. et al. (2021).
Toxicoepidemiology of poisoning exhibited in Indian
population from 2010 to 2020: A systematic review and
meta-analysis. BMJ Open 11 (5): e045182.
5 Pandey, J.K. (2022). Use of hazardous chemical
pesticides in india: a review. Proceedings of the National
Academy of Sciences, India Section B: Biological Sciences
93 (4): 1–15.
6 Butu, M., Stef, R., Grozea, I. et al. (2020). Biopesticides:
clean and viable technology for healthy environment.
In: Bioremediation and Biotechnology: Sustainable
Approaches to Pollution Degradation, 107–51.
Switzerland AG: Springer Nature.
7 Kumar, J., Ramlal, A., Mallick, D. et al. (2021). An
overview of some biopesticides and their importance
in plant protection for commercial acceptance. Plants
10 (6): 1185.
8 Ghodake, V.N., Naik, S.V., Bhukhanwala, K.N. et al.
(2018). Nanoengineered systems for biopesticides. In:
Handbook of Nanomaterials for Industrial Applications,
243–259. Netherlands: Elsevier.
9 Kalyabina, V.P., Esimbekova, E.N., Kopylova, K.V. et al.
(2021). Pesticides: Formulants, distribution pathways
and effects on human health–a review. Toxicology
Reports 8: 1179–92.
10 Sanvido, O., Schmid, K., FitzGerald, R.E. et al. (2018).
A quantitative risk assessment for skin sensitizing plant
protection products: linking derived No-Effect levels
(DNELs) with agricultural exposure models. Regulatory
Toxicology and Pharmacology 98: 171–83.
11 Deka, B., Bhattacharjee, B., Ahmed, A. et al. (2021).
Clinical management of allergic rhinitis: a
comprehensive review. Research Journal of
Pharmacology and Pharmacodynamics 13 (1): 9–16.
12 Singh, N.S., Sharma, R., Parween, T. et al. (2018).
Pesticide contamination and human health risk factor.
References 329
Modern Age Environmental Problems and their
Remediation 2018: 49–68.
13 Muhie, S.H. (2023). Concepts, principles, and
application of biodynamic farming: a review. Circular
Economy and Sustainability 3 (1): 291–304.
14 Mandakini, H. and Manamgoda, D.S. (2021). Microbial
biopesticides: development and application. In:
Microbial Technology for Sustainable Environment,
167–189. Cham: Springer.
15 Khursheed, A., Rather, M.A., Jain, V. et al. (2022). Plant
based natural products as potential ecofriendly and
safer biopesticides: a comprehensive overview of their
advantages over conventional pesticides, limitations
and regulatory aspects. Microbial Pathogenesis 173:
105854.
16 Ayilara, M.S., Adeleke, B.S., Akinola, S.A. et al. (2023).
Biopesticides as a promising alternative to synthetic
pesticides: a case for microbial pesticides,
phytopesticides, and nanobiopesticides. Frontiers in
Microbiology 14: 1040901.
17 Zhao, J., Liang, D., Li, W. et al. (2022). Research progress
on the synthetic biology of botanical biopesticides.
Bioengineering 9 (5): 207.
18 Šunjka, D. and Mechora, Š. (2022). An alternative source
of biopesticides and improvement in their
formulation—recent advances. Plants 11 (22): 3172.
19 Wylie, M.R. and Merrell, D.S. (2022). The antimicrobial
potential of the neem tree Azadirachta indica. Frontiers
in Pharmacology 13: 891535.
20 Elazzouzi, H., Fadili, K., Cherrat, A. et al. (2022).
Phytochemistry, biological and pharmacological
activities of the anacyclus pyrethrum (L.) lag:
a systematic review. Plants 11 (19): 2578.
21 Nascimento, V.F., Auad, A.M., de Resende, T.T. et al.
(2022). Insecticidal activity of aqueous extracts of plant
origin on mahanarva spectabilis (Distant, 1909)
(Hemiptera: Cercopidae). Agronomy 12 (4): 947.
22 Shang, A., Cao, S-Y., Xu, X-Y. et al. (2019). Bioactive
compounds and biological functions of garlic (Allium
sativum L.). Foods 8 (7): 246.
23 Costa, J., Sepúlveda, M., Gallardo, V. et al. (2022).
Antifungal potential of capsaicinoids and capsinoids
from the capsicum genus for the safeguarding of
agrifood production: advantages and limitations for
environmental health. Microorganisms 10 (12): 2387.
24 Amalraj, A., Pius, A., Gopi, S. et al. (2017). Biological
activities of curcuminoids, other biomolecules from
turmeric and their derivatives–a review. Journal of
Traditional and Complementary Medicine 7 (2): 205–33.
25 Mao, Q-Q., Xu, X-Y., Cao, S-Y. et al. (2019). Bioactive
compounds and bioactivities of ginger (Zingiber
officinale Roscoe). Foods 8 (6): 185.
26 Añibarro-Ortega, M., Pinela, J., Barros, L. et al. (2019).
Compositional features and bioactive properties of Aloe
vera leaf (fillet, mucilage, and rind) and flower.
Antioxidants 8 (10): 444.
27 Zubairi, S.I., Othman, Z.S., Sarmidi, M.R. et al. (2016).
Environmental friendly bio-pesticide Rotenone
extracted from Derris sp.: a review on the extraction
method, toxicity and field effectiveness. Journal
Teknologi 78: 47–69.
28 Ngegba, P.M., Cui, G., Khalid, M.Z. et al. (2022). Use of
botanical pesticides in agriculture as an alternative to
synthetic pesticides. Agriculture 12 (5): 600.
29 Biswas, K. and Sinha, S.N. (2022). Microbe-based
pesticides for insect pest control and their management.
In: Advances in Agricultural and Industrial Microbiology:
Volume-2: Applications of Microbes for Sustainable
Agriculture and in-silico Strategies, 165–76. New York:
Springer.
30 Shahid, M., Haq, E., Mohamed, A. et al. (2023).
Entomopathogen-based biopesticides: insights into
unraveling their potential in insect pest management.
Frontiers in Microbiology 14: 1208237.
31 Marrone, P.G. (2021). Status and potential of
bioprotection products for crop protection. In: Recent
Highlights in the Discovery and Optimization of Crop
Protection Products, 25–38. Netherlands: Elsevier.
32 Jain, N., Sharma, M.K. and Kaushik, P. (2022).
Therapeutically important bioactive compounds derived
from fungal origin. Therapeutic Implications of Natural
Bioactive Compounds 3: 223–35.
33 Fu, Y., Bhadha, J.H., Rott, P. et al. (2020). Investigating
the use of aquatic weeds as biopesticides towards
promoting sustainable agriculture. PloS One 15 (8):
e0237258.
34 Currie, J. and Walker, R. (2019). What do economists
have to say about the Clean Air Act 50 years after the
establishment of the Environmental Protection Agency?
Journal of Economic Perspectives 33 (4): 3–26.
35 Singh, S., Yadav, R., and Singh, A.N. (2023). Applications
of waste-to-economy practices in the urban wastewater
sector: implications for ecosystem, human health and
environment. In: Waste Management and Resource
Recycling in the Developing World, 625–46. Netherlands:
Elsevier.
36 Wu, T., Li, Z., Wu, Y. et al. (2023). Exploring plant
polyphenols as anti-allergic functional products to
330 16 Pesticides and Allergens
manage the growing incidence of food allergy. Frontiers
in Nutrition 10: 1102225.
37 Mlcek, J., Jurikova, T., Skrovankova, S. et al. (2016).
Quercetin and its anti-allergic immune response.
Molecules 21 (5): 623.
38 Hasan, M.K., Ara, I., Mondal, M.S.A. et al. (2021).
Phytochemistry, pharmacological activity, and potential
health benefits of Glycyrrhiza glabra. Heliyon 7 (6):
e07240.
39 Suntivich, R., Songjang, W., Jiraviriyakul, A. et al.
(2022). LC-MS/MS metabolomics-facilitated
identification of the active compounds responsible for
anti-allergic activity of the ethanol extract of Xenostegia
tridentata. PloS one 17 (4): e0265505.
40 Hęś, M., Dziedzic, K., Górecka, D. et al. (2019). Aloe
vera (L.) Webb.: Natural sources of antioxidants–a
review. Plant Foods for Human Nutrition 74: 255–65.
41 Kumar, P., Kamle, M., Mahato, D.K. et al. (2020).
Tinospora cordifolia (Giloy): Phytochemistry,
ethnopharmacology, clinical application and
conservation strategies. Current Pharmaceutical
Biotechnology 21 (12): 1165–75.
42 Islas, J.F., Acosta, E., Zuca, G. et al. (2020). An overview
of neem (Azadirachta indica) and its potential impact
on health. Journal of Functional Foods 74: 104171.
43 Chaudhary, A., Sharma, S., Mittal, A. et al. (2020).
Phytochemical and antioxidant profiling of Ocimum
sanctum. Journal of Food Science and Technology
57 (10): 3852–63.
44 Sah, A., Naseef, P.P., Kuruniyan, M.S. et al. (2022).
A comprehensive study of therapeutic applications
of chamomile. Pharmaceuticals 15 (10): 1284.
45 Bakhshaee, M., Esmaeili, M., Azad, F.J. et al. (2017).
Efficacy of supportive therapy of allergic rhinitis by
stinging nettle (Urtica dioica) root extract: a
randomized, double-blind, placebo-controlled, clinical
trial. Iranian Journal of Pharmaceutical Research: IJPR
16: 112.
46 Zhang, L., Fang, X., Sun, J. et al. (2023). Study on
synergistic anti-inflammatory effect of typical functional
components of extracts of ginkgo biloba leaves.
Molecules 28 (3): 1377.
47 Chaturvedi, D. (2019). Recent developments in the
anti-inflammatory potential of sesquiterpene lactones
and their semisynthetic analogs. In: Discovery and
Development of Anti-Inflammatory Agents from Natural
Products, 185–205. Amsterdam: Elsevier Science
Publishing Co Inc.
48 Beigoli, S., Behrouz, S., Memarzia, A. et al. (2021).
Effects of Allium cepa and its constituents on
respiratory and allergic disorders: a comprehensive
review of experimental and clinical evidence.
Evidence-based Complementary and Alternative
Medicine: eCAM 2021 (1): 5554259.
49 Cunha, N., Andrade, V., Ruivo, P. et al. (2023). Effects of
insect consumption on human health: a systematic
review of human studies. Nutrients 15 (14): 3076.
50 De Marchi, L., Wangorsch, A. and Zoccatelli, G. (2021).
Allergens from edible insects: cross-reactivity and
effects of processing. Current Allergy and Asthma
Reports 21: 1–12.
51 Pratap, K., Taki, A.C., Johnston, E.B. et al. (2020).
A comprehensive review on natural bioactive compounds
and probiotics as potential therapeutics in food allergy
treatment. Frontiers in Immunology 11: 996.
52 Šimat, V., Elabed, N., Kulawik, P. et al. (2020). Recent
advances in marine-based nutraceuticals and their
health benefits. Marine Drugs 18 (12): 627.
53 Quitério, E., Soares, C., Ferraz, R. et al. (2021). Marine
health-promoting compounds: recent trends for their
characterization and human applications. Foods 10 (12):
3100.
54 Elbandy, M. (2022). Anti-inflammatory effects of marine
bioactive compounds and their potential as functional
food ingredients in the prevention and treatment of
neuroinflammatory disorders. Molecules 28 (1): 2.
55 Playford, R.J. and Weiser, M.J. (2021). Bovine colostrum:
its constituents and uses. Nutrients 13 (1): 265.
56 Sangild, P.T., Vonderohe, C., Melendez Hebib, V. et al.
(2021). Potential benefits of bovine colostrum in
pediatric nutrition and health. Nutrients 13 (8): 2551.
57 Arslan, A., Kaplan, M., Duman, H. et al. (2021). Bovine
colostrum and its potential for human health and
nutrition. Frontiers in Nutrition 8: 651721.
58 Akram, W., Rihan, M., Ahmed, S. et al. (2023). Marine-
derived compounds applied in cardiovascular diseases:
submerged medicinal industry. Marine Drugs 21 (3): 193.
59 Pavel, C.I., Mărghitaş, L.A., Bobiş, O. et al. (2011).
Biological activities of royal jelly-review. Scientific
Papers Animal Science and Biotechnologies 44 (2):
108–18.
60 Gibson, G.R., Hutkins, R., Sanders, M.E. et al. (2017).
Expert consensus document: the international scientific
association for probiotics and prebiotics (ISAPP)
consensus statement on the definition and scope of
prebiotics. Nature Reviews Gastroenterology &
Hepatology 14 (8): 491–502.
61 Maizels, R.M. and McSorley, H.J. (2016). Regulation of
the host immune system by helminth parasites. Journal
of Allergy and Clinical Immunology 138 (3): 666–75.
62 Ege, M.J., Mayer, M., Normand, A-C. et al. (2011).
Exposure to environmental microorganisms and
childhood asthma. New England Journal of Medicine
364 (8): 701–9.